Home   Business   Life Science

Life Science




NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

Chesterford Research Park company’s strategy is described as ‘enormously promising’.


AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

CEO Pascal Soriot says he is ‘quite confident’ potential coronavirus vaccine will work - but admits it's a race to prove it.


Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

The money will support SMEs looking to access expertise or test products.


Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

The pharma company is carrying out groundbreaking work to fight Alzheimer’s.


Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Its reagents bind to the SARS-CoV-2 viral antigen.


IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

The Pampisford company will help identify suitable antibodies.


AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

The Cambridge company says the trials are a validation of its approach.


Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

The company has joined the platform, which is aimed at accelerating research and trials into potential therapies.


Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

The work reveals potential targets for tackling the high transmission of the coronavirus.


AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

They will adopt a non-profit approach during pandemic.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More